Introduction The aim of this study is to analyze all metastatic (M) categories of the current
tumor, node, and metastasis (TNM) classification of lung cancer with the objective of …

To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …

In 2017, the Seventieth World Health Assembly adopted resolution WHA70. 12 on Cancer
prevention and control in the context of an integrated approach (Appendix A). Operative …

Patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer
(NSCLC) often develop resistance to current standard third-generation EGFR tyrosine …

This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC)
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …

Primary lung cancer is the most common malignancy after nonmelanocytic skin cancer with
deaths from lung cancer exceeding those from any other type of malignancy worldwide [1] …

These NCCN Guidelines Insights focus on recent updates to the 2015 NCCN Guidelines for
Non–Small Cell Lung Cancer (NSCLC). Appropriate targeted therapy is very effective in …

Immune checkpoint inhibitors targeting programmed cell death 1 (PD-1), programmed cell
death ligand-1 (PD-L1), and others have shown potent clinical efficacy and have …

Background Necitumumab is a second-generation, recombinant, human immunoglobulin
G1 EGFR antibody. In this study, we aimed to compare treatment with necitumumab plus …